I am taking advantage of the current weak phase of Novo-Nordisk $NOVO B (-2,15%) to further expand my position and push down my entry price. The monthly savings plan was already increased from €50 to €75 in January and will continue until the share returns to its old days. The money corresponds to half the amount of my fully sold BYD $1211 (+0,57%) shares (53% profit). 🚘
In my opinion, extremely well positioned in the long term with specialization in products for diabetes and obesity treatment. 💉In addition, the dividend growth of approx. 22% p.a. over a 5-year period is unprecedentedly high. 🤑
I'm saving the second half for a possible further sell-off or a switch into the weakening beverage and snack giant PepsiCo $PEP (-0,39%). I also have a monthly savings plan here, which was recently raised from €50 to €75 to take advantage of the current weak phase. 💰
The market will definitely remain exciting for (re-)purchases in the coming days and weeks - what do you think? 🤔
